This federal contract award, identified as SPE2DB22D2103|SPE2DB25FR8RU, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $55,475.28, is for the delivery of Lotrel 10-20 mg capsules, a cardiovascular medication, to support military healthcare programs.
The contract is a Firm Fixed Price Delivery Order that runs through January 2, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization registered in the System for Award Management (SAM.gov) and has a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 4/1/25, 10:44 AM